Innate Antiviral Host Defense Attenuates TGF-β Function through IRF3-Mediated Suppression of Smad Signaling

Molecular Cell

Volumn 56, Issue 6, 2014, Pages 723-737

  Xu, Pinglong ^a,b   Bailey Bucktrout, Samantha ^c   Xi, Ying ^c   Xu, Daqi ^c   Du, Dan ^b   Zhang, Qian ^a   Xiang, Weiwen ^a   Liu, Jianming ^b   Melton, Andrew ^c   Sheppard, Dean ^c   Chapman, Harold A ^c   Bluestone, Jeffrey A ^c   Derynck, Rik ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; CELASTROL; INTERFERON REGULATORY FACTOR 3; NERVE CELL ADHESION MOLECULE; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN; VIMENTIN; IRF3 PROTEIN, HUMAN; SMAD3 PROTEIN; SMAD3 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SHAPE; CELL STRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCOMPETENT CELL; INFLUENZA; INNATE IMMUNITY; LUNG LAVAGE; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY T LYMPHOCYTE; TRANSACTIVATION; VIRUS INFECTION; ANIMAL; C57BL MOUSE; GENETIC TRANSCRIPTION; HEK293 CELL LINE; HEPG2 CELL LINE; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; SENDAI VIRUS; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

ANIMALS; CELL DIFFERENTIATION; EPITHELIAL-MESENCHYMAL TRANSITION; HEK293 CELLS; HEP G2 CELLS; HUMANS; IMMUNITY, INNATE; INTERFERON REGULATORY FACTOR-3; MICE, INBRED C57BL; SENDAI VIRUS; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; T-LYMPHOCYTES, REGULATORY; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84918802925     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2014.11.027     Document Type: Article

References (63)

1. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
2. Barrasa J.I., Olmo N., Santiago-Gómez A., Lecona E., Anglard P., Turnay J., Lizarbe M.A. Histone deacetylase inhibitors upregulate MMP11 gene expression through Sp1/Smad complexes in human colon adenocarcinoma cells. Biochim. Biophys. Acta 2012, 1823:570-581.
3. Belgnaoui S.M., Paz S., Hiscott J. Orchestrating the interferon antiviral response through the mitochondrial antiviral signaling (MAVS) adapter. Curr. Opin. Immunol. 2011, 23:564-572.
4. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., Weiner H.L., Kuchroo V.K. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory Tcells. Nature 2006, 441:235-238.
5. Brandl M., Seidler B., Haller F., Adamski J., Schmid R.M., Saur D., Schneider G. IKK(α) controls canonical TGF(ß)-SMAD signaling to regulate genes expressing SNAIL and SLUG during EMT in panc1 cells. J.Cell Sci. 2010, 123:4231-4239.
6. Chacko B.M., Qin B.Y., Tiwari A., Shi G., Lam S., Hayward L.J., De Caestecker M., Lin K. Structural basis of heteromeric smad protein assembly in TGF-β signaling. Mol. Cell 2004, 15:813-823.
7. Chapman H.A. Epithelial-mesenchymal interactions in pulmonary fibrosis. Annu. Rev. Physiol. 2011, 73:413-435.
8. Chen W., Jin W., Hardegen N., Lei K.J., Li L., Marinos N., McGrady G., Wahl S.M. Conversion of peripheral CD4+CD25- naive Tcells to CD4+CD25+ regulatory Tcells by TGF-β induction of transcription factor Foxp3. J.Exp. Med. 2003, 198:1875-1886.
9. Chipuk J.E., Cornelius S.C., Pultz N.J., Jorgensen J.S., Bonham M.J., Kim S.J., Danielpour D. The androgen receptor represses transforming growth factor-β signaling through interaction with Smad3. J.Biol. Chem. 2002, 277:1240-1248.
10. Clark K., Plater L., Peggie M., Cohen P. Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkappaB kinase epsilon: a distinct upstream kinase mediates Ser-172 phosphorylation and activation. J.Biol. Chem. 2009, 284:14136-14146.
11. Collins S.E., Mossman K.L. Danger, diversity and priming in innate antiviral immunity. Cytokine Growth Factor Rev. 2014, 25:525-531.
12. Curiel T.J. Tregs and rethinking cancer immunotherapy. J.Clin. Invest. 2007, 117:1167-1174.
13. Curotto de Lafaille M.A., Lafaille J.J. Natural and adaptive foxp3+ regulatory Tcells: more of the same or a division of labor?. Immunity 2009, 30:626-635.
14. Derynck R., Zhang Y.E. Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature 2003, 425:577-584.
15. Fantini M.C., Dominitzki S., Rizzo A., Neurath M.F., Becker C. Invitro generation of CD4+ CD25+ regulatory cells from murine naive Tcells. Nat. Protoc. 2007, 2:1789-1794.
16. Feng X.H., Derynck R. Specificity and versatility in tgf-β signaling through Smads. Annu. Rev. Cell Dev. Biol. 2005, 21:659-693.
17. Feng X.H., Zhang Y., Wu R.Y., Derynck R. The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-β-induced transcriptional activation. Genes Dev. 1998, 12:2153-2163.
18. Ink4B) transcription in response to TGF-β. EMBO J. 2000, 19:5178-5193.
19. Fitzgerald K.A., McWhirter S.M., Faia K.L., Rowe D.C., Latz E., Golenbock D.T., Coyle A.J., Liao S.M., Maniatis T. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 2003, 4:491-496.
20. Goubau D., Deddouche S., Reis e Sousa C. Cytosolic sensing of viruses. Immunity 2013, 38:855-869.
21. Hayashi H., Abdollah S., Qiu Y., Cai J., Xu Y.Y., Grinnell B.W., Richardson M.A., Topper J.N., Gimbrone M.A., Wrana J.L., Falb D. The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell 1997, 89:1165-1173.
22. Heldin C.H., Vanlandewijck M., Moustakas A. Regulation of EMT by TGFβ in cancer. FEBS Lett. 2012, 586:1959-1970.
23. Ikushima H., Miyazono K. TGFbeta signalling: a complex web in cancer progression. Nat. Rev. Cancer 2010, 10:415-424.
24. Imamura T., Takase M., Nishihara A., Oeda E., Hanai J., Kawabata M., Miyazono K. Smad6 inhibits signalling by the TGF-β superfamily. Nature 1997, 389:622-626.
25. Janknecht R., Wells N.J., Hunter T. TGF-β-stimulated cooperation of smad proteins with the coactivators CBP/p300. Genes Dev. 1998, 12:2114-2119.
26. Kato H., Takahasi K., Fujita T. RIG-I-like receptors: cytoplasmic sensors for non-self RNA. Immunol. Rev. 2011, 243:91-98.
27. Katsuno Y.L., Lamouille S., Derynck R. TGF-β signaling and epithelial-mesenchymal transition in cancer progression. Curr. Opin. Oncol. 2013, 25:76-84.
28. Kawasaki T., Kawai T., Akira S. Recognition of nucleic acids by pattern-recognition receptors and its relevance in autoimmunity. Immunol. Rev. 2011, 243:61-73.
29. Kim T.K., Lee J.S., Oh S.Y., Jin X., Choi Y.J., Lee T.H., Lee Eh., Choi Y.K., You S., Chung Y.G., et al. Direct transcriptional activation of promyelocytic leukemia protein by IFN regulatory factor 3 induces the p53-dependent growth inhibition of cancer cells. Cancer Res. 2007, 67:11133-11140.
30. Koinuma D., Tsutsumi S., Kamimura N., Taniguchi H., Miyazawa K., Sunamura M., Imamura T., Miyazono K., Aburatani H. Chromatin immunoprecipitation on microarray analysis of Smad2/3 binding sites reveals roles of ETS1 and TFAP2A in transforming growth factor β signaling. Mol. Cell. Biol. 2009, 29:172-186.
31. Kumar H., Kawai T., Kato H., Sato S., Takahashi K., Coban C., Yamamoto M., Uematsu S., Ishii K.J., Takeuchi O., Akira S. Essential role of IPS-1 in innate immune responses against RNA viruses. J.Exp. Med. 2006, 203:1795-1803.
32. Lamouille S., Derynck R. Cell size and invasion in TGF-β-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway. J.Cell Biol. 2007, 178:437-451.
33. Laping N.J., Grygielko E., Mathur A., Butter S., Bomberger J., Tweed C., Martin W., Fornwald J., Lehr R., Harling J., et al. Inhibition of transforming growth factor (TGF)-β1-induced extracellular matrix with a novel inhibitor of the TGF-β type I receptor kinase activity: SB-431542. Mol. Pharmacol. 2002, 62:58-64.
34. Li M.O., Flavell R.A. TGF-beta: a master of all Tcell trades. Cell 2008, 134:392-404.
35. Li G., Heaton J.H., Gelehrter T.D. Role of steroid receptor coactivators in glucocorticoid and transforming growth factor β regulation of plasminogen activator inhibitor gene expression. Mol. Endocrinol. 2006, 20:1025-1034.
36. Lin R., Heylbroeck C., Pitha P.M., Hiscott J. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol. Cell. Biol. 1998, 18:2986-2996.
37. Lin C.H., Hare B.J., Wagner G., Harrison S.C., Maniatis T., Fraenkel E. A small domain of CBP/p300 binds diverse proteins: solution structure and functional studies. Mol. Cell 2001, 8:581-590.
38. Marié I., Durbin J.E., Levy D.E. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J. 1998, 17:6660-6669.
39. Massagué J. TGFβ signalling in context. Nat. Rev. Mol. Cell Biol. 2012, 13:616-630.
40. Miyake T., Alli N.S., McDermott J.C. Nuclear function of Smad7 promotes myogenesis. Mol. Cell. Biol. 2010, 30:722-735.
41. Moustakas A., Kardassis D. Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. Proc. Natl. Acad. Sci. USA 1998, 95:6733-6738.
42. Nakao A., Afrakhte M., Morén A., Nakayama T., Christian J.L., Heuchel R., Itoh S., Kawabata M., Heldin N.E., Heldin C.H., ten Dijke P. Identification of Smad7, a TGFbeta-inducible antagonist of TGF-β signalling. Nature 1997, 389:631-635.
43. Qin B.Y., Liu C., Lam S.S., Srinath H., Delston R., Correia J.J., Derynck R., Lin K. Crystal structure of IRF-3 reveals mechanism of autoinhibition and virus-induced phosphoactivation. Nat. Struct. Biol. 2003, 10:913-921.
44. Qin B.Y., Liu C., Srinath H., Lam S.S., Correia J.J., Derynck R., Lin K. Crystal structure of IRF-3 in complex with CBP. Structure 2005, 13:1269-1277.
45. Qing J., Liu C., Choy L., Wu R.Y., Pagano J.S., Derynck R. Transforming growth factor beta/Smad3 signaling regulates IRF-7 function and transcriptional activation of the beta interferon promoter. Mol. Cell. Biol. 2004, 24:1411-1425.
46. Reily M.M., Pantoja C., Hu X., Chinenov Y., Rogatsky I. The GRIP1:IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppression. EMBO J. 2006, 25:108-117.
47. Scheel C., Weinberg R.A. Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Semin. Cancer Biol. 2012, 22:396-403.
48. Seoane J., Pouponnot C., Staller P., Schader M., Eilers M., Massagué J. TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b. Nat. Cell Biol. 2001, 3:400-408.
49. Sharma S., tenOever B.R., Grandvaux N., Zhou G.P., Lin R., Hiscott J. Triggering the interferon antiviral response through an IKK-related pathway. Science 2003, 300:1148-1151.
50. Sheppard D. Transforming growth factor β: a central modulator of pulmonary and airway inflammation and fibrosis. Proc. Am. Thorac. Soc. 2006, 3:413-417.
51. Sheridan B.S., Lefrançois L. Regional and mucosal memory Tcells. Nat. Immunol. 2011, 12:485-491.
52. Takahasi K., Suzuki N.N., Horiuchi M., Mori M., Suhara W., Okabe Y., Fukuhara Y., Terasawa H., Akira S., Fujita T., Inagaki F. X-ray crystal structure of IRF-3 and its functional implications. Nat. Struct. Biol. 2003, 10:922-927.
53. Thuault S., Valcourt U., Petersen M., Manfioletti G., Heldin C.H., Moustakas A. Transforming growth factor-β employs HMGA2 to elicit epithelial-mesenchymal transition. J.Cell Biol. 2006, 174:175-183.
54. Ulloa L., Doody J., Massagué J. Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway. Nature 1999, 397:710-713.
55. Wathelet M.G., Lin C.H., Parekh B.S., Ronco L.V., Howley P.M., Maniatis T. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-β enhancer invivo. Mol. Cell 1998, 1:507-518.
56. Weaver B.K., Kumar K.P., Reich N.C. Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1. Mol. Cell. Biol. 1998, 18:1359-1368.
57. Xu J., Lamouille S., Derynck R. TGF-β-induced epithelial to mesenchymal transition. Cell Res. 2009, 19:156-172.
58. Xu P., Liu J., Derynck R. Post-translational regulation of TGF-β receptor and Smad signaling. FEBS Lett. 2012, 586:1871-1884.
59. Yadav M., Louvet C., Davini D., Gardner J.M., Martinez-Llordella M., Bailey-Bucktrout S., Anthony B.A., Sverdrup F.M., Head R., Kuster D.J., et al. Neuropilin-1 distinguishes natural and inducible regulatory Tcells among regulatory Tcell subsets invivo. J Exp Med 2012, 209:1713-1722. S1711-1719.
60. Yang L., Pang Y., Moses H.L. TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression. Trends Immunol. 2010, 31:220-227.
61. Zhang S., Fei T., Zhang L., Zhang R., Chen F., Ning Y., Han Y., Feng X.H., Meng A., Chen Y.G. Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation. Mol. Cell Biol. 2007, 27:4488-4499.
62. Zhang Y.E. Non-Smad pathways in TGF-β signaling. Cell Res. 2009, 19:128-139.
63. Zhang Y., Feng X.H., Derynck R. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription. Nature 1998, 394:909-913.